Tata Motors' Jaguar Land Rover is scaling up production of protective face visors to support the fight against coronavirus.

New tooling will produce a further 14,000 visors each week for key workers across the UK.

Earlier this month, the carmaker announced the manufacture of 3D printed face visors at its product development centre in Gaydon, which it claims has one of the most advanced 3D printing facilities in Europe.

Visors have been produced and shipped to NHS Trusts across the UK, including the Great Western Hospitals NHS Foundation Trust and (local) South Warwickshire NHS Foundation Trust. 

Now using injection moulding tooling supplied by WHS Plastics of Sutton Coldfield, the operation will produce at least 2,000 per day with one polypropylene headband made every 30 seconds.

Jaguar Land Rover is also releasing its NHS-approved CAD design in the hope that businesses with additive manufacturing facilities will join the global call for more personal protection equipment (PPE).

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Each face visor has been designed to be reusable and can be easily dismantled and cleaned before being used again, safeguarding NHS trusts against future shortages.